Abnova (Taiwan) Market Cap

Abnova (Taiwan) has a market cap or net worth of 1.43 billion as of March 9, 2026. Its market cap has decreased by -22.33% in one year.

Market Cap

1.43B

Enterprise Value

1.07B

Revenue

351.30M

Ranking

n/a

PE Ratio

n/a

Stock Price

23.50

Market Cap Chart

Since May 27, 2008, Abnova (Taiwan)'s market cap has decreased from 2.91B to 1.43B, a decrease of -50.78%. That is a compound annual growth rate of -3.91%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	1.41B	2.86%
Dec 31, 2025	1.37B	-23.44%
Dec 31, 2024	1.80B	-15.53%
Dec 29, 2023	2.13B	-14.81%
Dec 30, 2022	2.49B	-5.40%
Dec 30, 2021	2.64B	-25.17%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Meribank Biotech	1.45B
NeoCore Technology	1.50B
Great Novel Therapeutics Biotech & Medicals	1.42B
GenMont Biotech Incorporation	1.54B
Enimmune	1.27B
Genomics BioSci & Tech.	1.75B
Advagene Biopharma	1.83B
Anti-Microbial Savior BioteQ	1.84B

Market Cap Rankings